These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23641326)

  • 1. Anti-counterfeit technologies: a pharmaceutical industry perspective.
    Bansal D; Malla S; Gudala K; Tiwari P
    Sci Pharm; 2013; 81(1):1-13. PubMed ID: 23641326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RFID in the pharmaceutical industry: addressing counterfeits with technology.
    Taylor D
    J Med Syst; 2014 Nov; 38(11):141. PubMed ID: 25308613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the Pharmaceutical Industry Benefit from Full-Scale Adoption of Radio-Frequency Identification (RFID) Technology with New Regulations?
    Coustasse A; Kimble CA; Stanton RB; Naylor M
    Perspect Health Inf Manag; 2016; 13(Fall):1b. PubMed ID: 27843419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the pharmacist in preventing distribution of counterfeit medications.
    Chambliss WG; Carroll WA; Kennedy D; Levine D; Moné MA; Ried LD; Shepherd M; Yelvigi M
    J Am Pharm Assoc (2003); 2012; 52(2):195-9. PubMed ID: 22370383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical counterfeiting and the RFID technology intervention.
    Coustasse A; Arvidson C; Rutsohn P
    J Hosp Mark Public Relations; 2010 Jul; 20(2):100-15. PubMed ID: 20582850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The silent development of counterfeit medications in developing countries - A systematic review of detection technologies.
    Bolla AS; Patel AR; Priefer R
    Int J Pharm; 2020 Sep; 587():119702. PubMed ID: 32736015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traceability and Risk Analysis Strategies for Addressing Counterfeit Electronics in Supply Chains for Complex Systems.
    DiMase D; Collier ZA; Carlson J; Gray RB; Linkov I
    Risk Anal; 2016 Oct; 36(10):1834-1843. PubMed ID: 26800103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry.
    Uddin M
    Int J Pharm; 2021 Mar; 597():120235. PubMed ID: 33549813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of existing and emerging digital technologies to combat the global trade in fake medicines.
    Mackey TK; Nayyar G
    Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticounterfeit packaging technologies.
    Shah RY; Prajapati PN; Agrawal YK
    J Adv Pharm Technol Res; 2010 Oct; 1(4):368-73. PubMed ID: 22247875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].
    Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J
    Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
    Kumar B; Baldi A
    Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Historical sketch of modern pharmaceutical science and technology (Part 4). Post World War II 50 years].
    Yamakawa K
    Yakushigaku Zasshi; 1995; 30(2):75-90. PubMed ID: 11613536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA, companies test RFID tracking to prevent drug counterfeiting.
    James JS
    AIDS Treat News; 2005 Dec; (417):5-8. PubMed ID: 16541509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All the players in the game: driving home the global commitment for legitimate drugs.
    Babyar J
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1868-1870. PubMed ID: 30114946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan.
    Alfadl AA; Hassali MA; Ibrahim MI
    Res Social Adm Pharm; 2013; 9(3):302-10. PubMed ID: 22835708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.